Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG).
Rudick RA, Simonian NA, Alam JA, Campion M, Scaramucci JO, Jones W, Coats ME, Goodkin DE, Weinstock-Guttman B, Herndon RM, Mass MK, Richert JR, Salazar AM, Munschauer FE 3rd, Cookfair DL, Simon JH, Jacobs LD.
Rudick RA, et al.
Neurology. 1998 May;50(5):1266-72. doi: 10.1212/wnl.50.5.1266.
Neurology. 1998.
PMID: 9595973
Clinical Trial.